$23.00 0.11 (+0.48%)
11/6/2009 4:00 PM

Endo Pharmaceuticals (ENDP)

CAPS Rating: 5 out of 5

A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.

Recs

7
Member Avatar tenmiles (99.99) Submitted: 4/2/2009 10:18:12 AM : Outperform Start Price: $18.04 ENDP Score: -2.36

Adding a little Percocet to the portfolio. Pharma dealing with various pain control products offers strong balance sheet with high ROE; likely to show relative strength later in the summer in advance of FDA decision on marketing application for NEBIDO - buyer around $18

Report this Post 1 Comment
Member Avatar toolboy2 (98.13) Submitted: 5/20/2009 11:29:38 AM
Recs: 0 Rec This

I'm hoping to pick this up around $15 for my real portfolio, but $16 isn't too bad for my CAPS entry. :) Carries quite a bit of debt, but cash flow looks good.

Report this Post

Featured Broker Partners